IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites
Status:
Not yet recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy of IFN- Y combined with T cells in the
treatment of refractory malignant pleural effusion and acties, using a multicenter,
single-arm, open design.